Pembrolizumab-Induced Hypertrophic Lichenoid Dermatitis and Bullous Pemphigoid in One Patient

被引：1
|
作者：
Alsabbagh, Manal [1 ,3 ]
Bava, Aneesh [1 ]
Ansari, Sameer [2 ]
机构：
[1] King Hamad Univ Hosp, Dept Dermatol, Busaiteen, Bahrain
[2] King Hamad Univ Hosp, Dept Pathol, Busaiteen, Bahrain
[3] Bldg 2435,Rd 2835,Block 228,POB 24343, Busaiteen, Bahrain
来源：
INDIAN DERMATOLOGY ONLINE JOURNAL | 2024年 / 15卷 / 03期
关键词：
CORTICOSTEROIDS;
D O I：
10.4103/idoj.IDOJ_353_23
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [1] Pembrolizumab-induced bullous pemphigoid
    Kartha, Virginia
    Owen, Cindy
    Callen, Jeffrey P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB218 - AB218
  • [2] Pembrolizumab-induced hypertrophic lichenoid dermatitis with involvement of an old tattoo
    Bala, Laksha
    Hussain, Khawar
    Shetty, Rashmi
    Patel, Neil P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [3] Pembrolizumab-induced reactivation of bullous pemphigoid
    Kaul, Subuhi
    Wang, Allison
    Grushchak, Solomiya
    Albrecht, Joerg
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (06) : 757 - 758
  • [4] Pembrolizumab-Induced Bullous Pemphigoid Treated With Rituximab
    Sharma, Pritha
    Barnes, Martin
    Nabeel, Shaha
    LiPera, William
    JCO ONCOLOGY PRACTICE, 2020, 16 (11) : 764 - +
  • [5] Pembrolizumab-Induced Lichenoid Dermatitis in a Patient With Metastatic Cancer of Unknown Primary
    Sethi, Ashish
    Raj, Moses
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [6] Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
    Honigman, A.
    Lai, F.
    Elakis, J.
    Prall, O.
    Goh, M.
    McCormack, C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 47 - 47
  • [7] Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
    Honigman, Anthony D.
    Lai, Franks
    Elakis, Joshua
    Prall, Owen
    Goh, Michelle
    McCormack, Christopher
    CLINICAL CASE REPORTS, 2019, 7 (04): : 773 - 775
  • [8] Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid
    Wang, Jianglin
    Hu, Xin
    Jiang, Wei
    Zhou, Wenjie
    Tang, Mengjie
    Wu, Cuifang
    Liu, Wei
    Zuo, Xiaocong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanoma
    Vanyai, Beatrix
    Chien, Yi-Che Chang
    Beke, Livia
    Szabo, Imre Lorinc
    Peter, Zoltan
    Steuer-Hajdu, Krisztina
    Varvolgyi, Tunde
    Mehes, Gabor
    Emri, Gabriella
    IMMUNOTHERAPY, 2022, 14 (17) : 1377 - 1382
  • [10] Dupilumab for the treatment of pembrolizumab-induced bullous pemphigoid: A case report
    Pop, Samantha R.
    Strock, Daniel
    Smith, Robert J.
    DERMATOLOGIC THERAPY, 2022, 35 (08)
12345